C12N 2710/16722
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2710/16722 (New viral proteins or individual genes, new structural or functional aspects of) appears on 252 US grants and 132 published applications in this corpus.
Search patents in C12N- Granted patents
- 252
- Published applications
- 132
- Assignees
- 129
- Inventors
- 461
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 9 | 0 |
| 1992 | 5 | 0 |
| 1993 | 7 | 0 |
| 1994 | 9 | 0 |
| 1995 | 9 | 0 |
| 1996 | 12 | 0 |
| 1997 | 15 | 0 |
| 1998 | 37 | 0 |
| 1999 | 17 | 0 |
| 2000 | 14 | 0 |
| 2001 | 23 | 3 |
| 2002 | 7 | 7 |
| 2003 | 9 | 14 |
| 2004 | 7 | 8 |
| 2005 | 5 | 4 |
| 2006 | 5 | 5 |
| 2007 | 4 | 1 |
| 2008 | 2 | 12 |
| 2009 | 2 | 1 |
| 2010 | 2 | 5 |
| 2011 | 3 | 4 |
| 2012 | 0 | 3 |
| 2013 | 0 | 5 |
| 2014 | 3 | 3 |
| 2015 | 2 | 2 |
| 2016 | 3 | 5 |
| 2017 | 4 | 0 |
| 2018 | 2 | 4 |
| 2019 | 3 | 2 |
| 2020 | 2 | 6 |
| 2021 | 3 | 4 |
| 2022 | 5 | 8 |
| 2023 | 4 | 6 |
| 2024 | 4 | 6 |
| 2025 | 3 | 9 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Varicella zoster virus (VZV) vaccine12 May 2026US 12,622,960 B2ModernaTX, Inc.
- Recombinant nucleic acids containing alphaherpesvirus promoter sequences17 Feb 2026US 12,551,574 B2The Trustees of Princeton University
- Herpes zoster mRNA vaccine, preparation method therefor, and use thereof25 Nov 2025US 12,478,669 B1Hangzhou Tianlong Pharmaceutical Co., Ltd.
- RNA vaccines against infectious diseases8 Jul 2025US 12,350,329 B2HDT Bio Corp.
- Recombinant virus with diminished latency and methods of using same13 May 2025US 12,296,004 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Mutated fragment of vzv glycoprotein e1 Oct 2026US 2026/0295035 A1
- A Fusion Protein and a Particulate Antigen Containing the Same27 Aug 2026US 2026/0250328 A1Xiamen Innovax Biotech Co., Ltd.
- Fusion protein of ge and gi of varicella-zoster virus and use6 Aug 2026US 2026/0224694 A1
- Nucleic Acid Vaccines for Varicella-Zoster Virus (VZV)6 Aug 2026US 2026/0224695 A1Everest Medicines (Singapore) Pte. Ltd.
- Herpesviral combination therapy for targeting cancer cells and cancer associated stromal cells11 Jun 2026US 2026/0158087 A1Mayo Foundation for Medical Education and Research
Most cited
By later US patents
- Eukaryotic layered vector initiation systems204US 5,814,482 A1998
- Alphavirus vector constructs167US 5,843,723 AChiron Corporation · 1998
- Alphavirus structural protein expression cassettes152US 5,789,245 AChiron Corporation · 1998
- NYVAC vaccinia virus recombinants comprising heterologous inserts137US 5,494,807 AVirogenetics Corporation · 1996
- Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence128US 5,833,975 AVirogenetics Corporation · 1998